COVID-19：中国Shinofarm疫苗：秘鲁的“试验中止”
-参与者的手臂瘫痪-
中国：筱野农场
秘鲁国家卫生研究所：
目前，中国正在秘鲁进行中国国家药品和疫苗的临床试验。
秘鲁国家卫生中心突然暂停了“ Sinofarm” COVID-19疫苗的试验。
在12月11日（当地时间），原因已明确。
法国法新社通讯：
该临床试验的中止是由于一名参与者由于“吉兰谷综合症”而无法移动手臂。
wowkorea.jp
http://www.wowkorea.jp/news/Korea/2020/1212/10280470.html
Peru suspends clinical trials of Chinese COVID-19 vaccine
LIMA: Peru
has temporarily suspended clinical trials of a COVID-19 vaccine made by Chinese drug giant Sinopharm after detecting neurological problems in one of its test volunteers.
The National Institute of Health
said on Friday (Dec 11) that it had decided to interrupt the trial after a volunteer had difficulty moving their arms, according to local media.
Several days ago
we signalled, as we are required, to the regulatory authorities that one of our participants (in trials) presented neurological symptoms
which could correspond to a condition called Guillain-Barre syndrome,” said chief researcher German Malaga in comments to the press.
Guillain-Barre syndrome
is a rare and non-contagious disorder which affects the movement of the arms and legs.
Peru declared
a temporary health emergency in five regions in June last year following multiple cases.
CNA
Peru halts Chinese coronavirus vaccine trials after volunteer develops neurological problems